Donate to Science & Enterprise

S&E on Mastodon

S&E on LinkedIn

S&E on Flipboard

Please share Science & Enterprise

AI-Designed Cancer Vaccine Shown to Act Against Melanoma

T-cells and cancer cells

Results of a small clinical trial show most patients with melanoma receiving a personalized therapeutic vaccine with an approved immunotherapy reduced at least some of their tumors. . . . → Read More: AI-Designed Cancer Vaccine Shown to Act Against Melanoma

Low-Dose Oral Film Reduces Mental Disorder Agitation

Depression

Interim results from a clinical trial show a drug given as a dissolvable oral film in a lower dose reduces agitation in people with bipolar disorder and schizophrenia. . . . → Read More: Low-Dose Oral Film Reduces Mental Disorder Agitation

Pharma Company Gains Precise Gene Edits in $2B Biotech Deal

Editing DNA

A global drug maker is acquiring access to a biotechnology company’s precise genome editing techniques to develop new therapies for rare and cardiometabolic disorders. . . . → Read More: Pharma Company Gains Precise Gene Edits in $2B Biotech Deal

Lab to Develop New Bio-Based Sustainable Materials

Climate change illustration

A venture investment fund and university bioengineering center are creating a laboratory to design more sustainable alternative materials to help address the climate crisis. . . . → Read More: Lab to Develop New Bio-Based Sustainable Materials

Safer Forms of Psilocybin Assessed in Preclinical Study

Psilocybin mushrooms

A biotechnology company says it identified engineered precursors of a psychedelic compound that in lab animals produce safe and intended therapeutic effects. . . . → Read More: Safer Forms of Psilocybin Assessed in Preclinical Study

Brain-Computer Device Company Gains $33M in Early Funds

Electrode microarray illustration

A company creating brain-computer interface devices to help people with disabling communications impairments is raising $33 million in its first venture round. . . . → Read More: Brain-Computer Device Company Gains $33M in Early Funds

Measles-Rubella Patch Vaccine Shown Effective as Injection

Child receiving vaccine patch

A clinical trial shows a peel-and-stick patch device is as effective as a standard syringe injection in delivering a vaccine that protects against measles and rubella. . . . → Read More: Measles-Rubella Patch Vaccine Shown Effective as Injection

Biotech, Janssen Partner on Ultrasound for Gene Therapy

Small bubbles

A developer of ultrasound bubbles to assist gene therapies is studying use of the technology with Janssen Pharmaceuticals for delivering DNA and RNA treatments. . . . → Read More: Biotech, Janssen Partner on Ultrasound for Gene Therapy

Rare Disease Search Adds Large Language Model A.I.

Artificial intelligence graphic

A company offering a search engine to help diagnose rare diseases is integrating generative models from Open AI into its artificial intelligence algorithms. . . . → Read More: Rare Disease Search Adds Large Language Model A.I.

Infographic – Climate Start-Ups Still Gaining Venture Funds

Bar chart: Annual venture funding for weather and climate start-ups through 2022

Despite a sharp downturn in venture dollars from 2021, new climate and weather forecasting companies continue to attract investments at historically high rates. . . . → Read More: Infographic – Climate Start-Ups Still Gaining Venture Funds